Use of intraoperative cell-salvage for autologous blood transfusions in metastatic spine tumour surgery: A systematic review

The Lancet Oncology

Volumn 15, Issue 1, 2014, Pages

  Kumar, Naresh ^a   Chen, Yongsheng ^a   Zaw, Aye S ^a   Nayak, Deepti ^a   Ahmed, Qasim ^b   Soong, Richie ^b   Wong, Hee K ^a  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD AUTOTRANSFUSION; CANCER CELL; CANCER SURGERY; CELL SELECTION; CELL SEPARATION; DIGESTIVE SYSTEM CANCER; GYNECOLOGIC CANCER; HEPATOBILIARY SYSTEM CANCER; HUMAN; IN VITRO STUDY; INTRAOPERATIVE CELL SALVAGE; LUNG CANCER; METASTASIS; METASTATIC MUSCULOSKELETAL TUMOR SURGERY; METASTATIC SPINE TUMOR SURGERY; OPERATIVE BLOOD LOSS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; SALVAGE THERAPY; SPINE TUMOR; SYSTEMATIC REVIEW; URINARY TRACT CANCER;

EID: 84891366733     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(13)70245-6     Document Type: Review

References (67)

1. Hage WD, Aboulafia AJ, Aboulafia DM Incidence, location, and diagnostic evaluation of metastatic bone disease. Orthop Clin North Am 2000, 31:515-528.
2. Gokaslan ZL, York JE, Walsh GL, et al. Transthoracic vertebrectomy for metastatic spinal tumors. J Neurosurg 1998, 89:599-609.
3. Sciubba DM, Petteys RJ, Dekutoski MB, et al. Diagnosis and management of metastatic spine disease. J Neurosurg Spine 2010, 13:94-108.
4. Jacobs WB, Perrin RG Evaluation and treatment of spinal metastases: an overview. Neurosurg Focus 2001, 11:e10.
5. Kumar N, Chen Y, Nath C, Liu EH What is the role of autologous blood transfusion in major spine surgery?. Am J Orthop (Belle Mead NJ) 2012, 41:E89-E95.
6. Carson JL, Duff A, Poses RM, et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996, 348:1055-1060.
7. Bilsky MH, Fraser JF Complication avoidance in vertebral column spine tumors. Neurosurg Clin North Am 2006, 17:317-329.
8. Chen Y, Tai BC, Nayak D, et al. Blood loss in spinal tumour surgery and surgery for metastatic spinal disease: a meta-analysis. Bone Joint J 2013, 95-B:683-688.
9. Wang JC, Boland P, Mitra N, et al. Single-stage posterolateral transpedicular approach for resection of epidural metastatic spine tumors involving the vertebral body with circumferential reconstruction: results in 140 patients. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004. J Neurosurg Spine 2004, 1:287-298.
10. Miller GV, Ramsden CW, Primrose JN Autologous transfusion: an alternative to transfusion with banked blood during surgery for cancer. Br J Surg 1991, 78:713-715.
11. Blajchman MA, Bordin JO The tumor growth-promoting effect of allogeneic blood transfusions. Immunol Invest 1995, 24:311-317.
12. Ashworth A, Klein AA Cell salvage as part of a blood conservation strategy in anaesthesia. Br J Anaesth 2010, 105:401-416.
13. Blumberg N Allogeneic transfusion and infection: economic and clinical implications. Semin Hematol 1997, 34:34-40.
14. Bolton-Maggs P, Cohen H Annual SHOT report 2011. Report (accessed Dec 25, 2012). http://www.shotuk.org/wp-content/uploads/2012/07/SHOT-Summary_FinalWebVersion2012_06_261.pdf.
15. Cha CW, Deible C, Muzzonigro T, Lopez-Plaza I, Vogt M, Kang JD Allogeneic transfusion requirements after autologous donations in posterior lumbar surgeries. Spine (Phila Pa 1976) 2002, 27:99-104.
16. Hu SS Blood loss in adult spinal surgery. Eur Spine J 2004, 13(suppl 1):S3-S5.
17. McKenna SJ Autologous blood transfusions. Council on Scientific Affairs. JAMA 1986, 256:2378-2380.
18. Szpalski M, Gunzburg R, Sztern B An overview of blood-sparing techniques used in spine surgery during the perioperative period. Eur Spine J 2004, 13(suppl 1):S18-S27.
19. Brookfield KF, Brown MD, Henriques SM, Buttacavoli FA, Seitz AP Allogeneic transfusion after predonation of blood for elective spine surgery. Clin Orthop Relat Res 2008, 466:1949-1953.
20. Epstein NE Bloodless spinal surgery: a review of the normovolemic hemodilution technique. Surg Neurol 2008, 70:614-618.
21. Savvidou C, Chatziioannou SN, Pilichou A, Pneumaticos SG Efficacy and cost-effectiveness of cell saving blood autotransfusion in adult lumbar fusion. Transfus Med 2009, 19:202-206.
22. Flynn JC, Metzger CR, Csencsitz TA Intraoperative autotransfusion (IAT) in spinal surgery. Spine (Phila Pa 1976) 1982, 7:432-435.
23. Cavallieri S, Riou B, Roche S, Ducart A, Roy-Camille R, Viars P Intraoperative autologous transfusion in emergency surgery for spine trauma. J Trauma 1994, 36:639-643.
24. Catling S, Williams S, Freites O, Rees M, Davies C, Hopkins L Use of a leucocyte filter to remove tumour cells from intra-operative cell salvage blood. Anaesthesia 2008, 63:1332-1338.
25. Waters JH, Yazer M, Chen YF, Kloke J Blood salvage and cancer surgery: a meta-analysis of available studies. Transfusion 2012, 52:2167-2173.
26. Bower MR, Ellis SF, Scoggins CR, McMasters KM, Martin RC Phase II comparison study of intraoperative autotransfusion for major oncologic procedures. Ann Surg Oncol 2011, 18:166-173.
27. Connor JP, Morris PC, Alagoz T, Anderson B, Bottles K, Buller RE Intraoperative autologous blood collection and autotransfusion in the surgical management of early cancers of the uterine cervix. Obstet Gynecol 1995, 86:373-378.
28. Gray CL, Amling CL, Polston GR, Powell CR, Kane CJ Intraoperative cell salvage in radical retropubic prostatectomy. Urology 2001, 58:740-745.
29. Hart OJ, Klimberg IW, Wajsman Z, Baker J Intraoperative autotransfusion in radical cystectomy for carcinoma of the bladder. Surg Gynecol Obstet 1989, 168:302-306.
30. Kim JM, Kim GS, Joh JW, et al. Long-term results for living donor liver transplant recipients with hepatocellular carcinoma using intraoperative blood salvage with leukocyte depletion filter. Transpl Int 2012, 26:84-89.
31. Gwak MS, Lee KW, Kim SY, et al. Can a leukocyte depletion filter (LDF) reduce the risk of reintroduction of hepatocellular carcinoma cells?. Liver Transpl 2005, 11:331-335.
32. Liang TB, Li DL, Liang L, et al. Intraoperative blood salvage during liver transplantation in patients with hepatocellular carcinoma: efficiency of leukocyte depletion filters in the removal of tumor cells. Transplantation 2008, 85:863-869.
33. Muller M, Kuhn DF, Hinrichs B, et al. Is the elimination of osteosarcoma cells with intraoperative 'mesh autotransfusion' and leukocyte depletion filters possible?. Anaesthesist 1996, 45:834-838.
34. Howick J. OCEBM Levels of Evidence Working Group. The Oxford 2011 Levels of Evidence. 2011.
35. Mirhashemi R, Averette HE, Deepika K, et al. The impact of intraoperative autologous blood transfusion during type III radical hysterectomy for early-stage cervical cancer. Am J Obstet Gynecol 1999, 181:1310-1315. discussion 5-6.
36. Beck-Schimmer B, Romero B, Booy C, et al. Release of inflammatory mediators in irradiated cell salvage blood and their biological consequences in human beings following transfusion. Eur J Anaesthesiol 2004, 21:46-52.
37. Fujimoto J, Okamoto E, Yamanaka N, et al. Efficacy of autotransfusion in hepatectomy for hepatocellular carcinoma. Arch Surg 1993, 128:1065-1069.
38. Zulim RA, Rocco M, Goodnight JE, Smith GJ, Krag DN, Schneider PD Intraoperative autotransfusion in hepatic resection for malignancy. Is it safe?. Arch Surg 1993, 128:206-211.
39. Muscari F, Suc B, Vigouroux D, et al. Blood salvage autotransfusion during transplantation for hepatocarcinoma: does it increase the risk of neoplastic recurrence?. Transpl Int 2005, 18:1236-1239.
40. Foltys D, Zimmermann T, Heise M, et al. Liver transplantation for hepatocellular carcinoma-is there a risk of recurrence caused by intraoperative blood salvage autotransfusion?. Eur Surg Res 2011, 47:182-187.
41. Martin RC, Wellhausen SR, Moehle DA, Martin AW, McMasters KM Evaluation of intraoperative autotransfusion filtration for hepatectomy and pancreatectomy. Ann Surg Oncol 2005, 12:1017-1024.
42. Klimberg I, Sirois R, Wajsman Z, Baker J Intraoperative autotransfusion in urologic oncology. Arch Surg 1986, 121:1326-1329.
43. Pisters LL, Wajsman Z Use of predeposit autologous blood and intraoperative autotransfusion in urologic cancer surgery. Urology 1992, 40:211-215.
44. Park KI, Kojima O, Tomoyoshi T Intra-operative autotransfusion in radical cystectomy. Br J Urol 1997, 79:717-721.
45. Davis M, Sofer M, Gomez-Marin O, Bruck D, Soloway MS The use of cell salvage during radical retropubic prostatectomy: does it influence cancer recurrence?. BJU Int 2003, 91:474-476.
46. Nieder AM, Carmack AJ, Sved PD, Kim SS, Manoharan M, Soloway MS Intraoperative cell salvage during radical prostatectomy is not associated with greater biochemical recurrence rate. Urology 2005, 65:730-734.
47. Ford BS, Sharma S, Rezaishiraz H, Huben RS, Mohler JL Effect of perioperative blood transfusion on prostate cancer recurrence. Urol Oncol 2008, 26:364-367.
48. MacIvor D, Nelson J, Triulzi D Impact of intraoperative red blood cell salvage on transfusion requirements and outcomes in radical prostatectomy. Transfusion 2009, 49:1431-1434.
49. Stoffel JT, Topjian L, Libertino JA Analysis of peripheral blood for prostate cells after autologous transfusion given during radical prostatectomy. BJU Int 2005, 96:313-315.
50. Nieder AM, Manoharan M, Yang Y, Soloway MS Intraoperative cell salvage during radical cystectomy does not affect long-term survival. Urology 2007, 69:881-884.
51. Ubee S, Kumar M, Athmanathan N, Singh G, Vesey S Intraoperative red blood cell salvage and autologous transfusion during open radical retropubic prostatectomy: a cost-benefit analysis. Ann R Coll Surg Engl 2011, 93:157-161.
52. Gorin MA, Eldefrawy A, Manoharan M, Soloway MS Oncologic outcomes following radical prostatectomy with intraoperative cell salvage. World J Urol 2012, 30:379-383.
53. Raval JS, Nelson JB, Woldemichael E, Triulzi DJ Intraoperative cell salvage in radical prostatectomy does not appear to increase long-term biochemical recurrence, metastases, or mortality. Transfusion 2012, 52:2590-2593.
54. Poli M, Camargo A, Villa L, Moura R, Colella R, Deheinzelin D Intraoperative autologous blood recovery in prostate cancer surgery: in vivo validation using a tumour marker. Vox Sang 2008, 95:308-312.
55. Perseghin P, Vigano M, Rocco G, Della Pona C, Buscemi A, Rizzi A Effectiveness of leukocyte filters in reducing tumor cell contamination after intraoperative blood salvage in lung cancer patients. Vox Sang 1997, 72:221-224.
56. Edelman MJ, Potter P, Mahaffey KG, Frink R, Leidich RB The potential for reintroduction of tumor cells during intraoperative blood salvage: reduction of risk with use of the RC-400 leukocyte depletion filter. Urology 1996, 47:179-181.
57. Futamura N, Nakanishi H, Hirose H, Nakamura S, Tatematsu M The effect of storage on the survival of cancer cells in blood and efficient elimination of contaminating cancer cells by a leukocyte depletion filter. Am Surg 2005, 71:585-590.
58. Hughes KS, Simon R, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery 1986, 100:278-284.
59. Chiusano MA, Finkelstein LH, Mene M, Ginsberg PC Use of predeposited autologous blood plus intraoperative autotransfusion compared with use of predeposited autologous blood alone in radical retropubic prostatectomy. J Am Osteopath Assoc 1996, 96:160-164.
60. Moll R Cytokeratins as markers of differentiation in the diagnosis of epithelial tumors. Subcell Biochem 1998, 31:205-262.
61. Tseng SCG, Jarvinen MJ, Nelson WG, Huang J-W, Woodcock-Mitchell J, Sun T-T Correlation of specific keratins with different types of epithelial differentiation: monoclonal antibody studies. Cell 1982, 30:361-372.
62. Woodcock-Mitchell J, Eichner R, Nelson WG, Sun TT Immunolocalization of keratin polypeptides in human epidermis using monoclonal antibodies. J Cell Biol 1982, 95:580-588.
63. Fabisiewicz A, Kulik J, Kober P, Brewczynska E, Pienkowski T, Siedlecki JA Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay. Acta Biochim Pol 2004, 51:747-755.
64. Ring AE, Zabaglo L, Ormerod MG, Smith IE, Dowsett M Detection of circulating epithelial cells in the blood of patients with breast cancer: comparison of three techniques. Br J Cancer 2005, 92:906-912.
65. Van der Auwera I, Peeters D, Benoy IH, et al. Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer. Br J Cancer 2010, 102:276-284.
66. Web P, Bain C Essential epidemiology: an introduction for students and health professionals 2010, Cambridge University Press, Cambridge.
67. Chen Y, Kumar N, Ahmed Q, Lee V, Lam RWM, Wong HK. Eliminating tumour cells from the cell saver (CS) in metastatic spine tumour surgery using a leucocyte depletion filter (LDF): dispelling an old myth. Paper presented at: The International Society for the Advancement of Spine Surgery (ISASS13); April 4 2013; Vancouver, Canada. Abstract number #91.